Adriaanse, Marlou; Leffler, Daniel A.; Kelly, Ciaran P. et al.
Serum I-Fabp Is a Useful Tool for Evaluation of Gluten Challenge in Adults With Celiac DiseaseGASTROENTEROLOGY. Bd. 144. H. 5. 2013 S. S14-S15
Kornek, M.; Lynch, M.; Afdhal, N. H. et al.
SERUM MICROPARTICLES (MP) AS A NOVEL TOOL TO IDENTIFY HEPATOCELLULAR CARCINOMA (HCC)JOURNAL OF HEPATOLOGY. Bd. 58. 2013 S. S266-S267
Wehler, Thomas C.; Hamdi, Swaantje; Maderer, Annett et al.
Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft-no benefit of combination therapyINTERNATIONAL JOURNAL OF COLORECTAL DISEASE. Bd. 28. H. 3. 2013 S. 385-398
Marquardt, Jens U.; Fischer, Kerstin; Baus, Katharina et al.
Sirtuin-6-Dependent Genetic and Epigenetic Alterations Are Associated With Poor Clinical Outcome in Hepatocellular Carcinoma PatientsHEPATOLOGY. Bd. 58. H. 3. 2013 S. 1054-1064
Witt, M.; Grunke, M.; Proft, F. et al.
SOPHIA TITLELUPUS. Bd. 22. H. 11. 2013 S. 1142-1149
Koch, S.; Niederle, I.; Gamstaetter, T. et al.
Sorafenib in advanced hepatocellular carcinoma (HCC) : Ascites as prognostic factorINTERNIST. Bd. 54. H. 6. 2013 S. 745-745
Koch, S.; Niederle, I.; Gamstaetter, T. et al.
Sorafenib in advanced hepatocellular carcinoma (HCC) : Ascites as prognostic factorINTERNIST. Bd. 54. 2013 S. 10-10
Sprinzl, Martin Franz; Reisinger, Florian; Puschnik, Andreas et al.
Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cellsHEPATOLOGY. Bd. 57. H. 6. 2013 S. 2358-2368
Kitade, Mitsuteru; Factor, Valentina M.; Andersen, Jesper B. et al.
Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signalingGENES & DEVELOPMENT. Bd. 27. H. 15. 2013 S. 1706-1717
Calvente, C.; Diken, M.; Sehgal, A. et al.
SPECIFIC IN VIVO DELIVERY OF PROCOLLAGEN alpha 1(I) siRNA IN LIPID-LIKE CARRIERS INHIBITS THE PROGRESSION OF BILIARY LIVER FIBROSISJOURNAL OF HEPATOLOGY. Bd. 58. 2013 S. S236-S236